Sugi Predict

Sugi Predict / Compounds / SCHEMBL19477455

SCHEMBL19477455

SCHEMBL19477455

CNc1ccnc(Nc2ccc(OC)c(OCC[C@@H](C)N3CCC3)c2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EHMT2 Q96KQ7 2/20 0.55
▸ EHMT1 Q9H9B1 1/20 0.55
▸ IGF1R P08069 13/20 0.47
▸ PLK4 O00444 2/20 0.46
▸ AURKA O14965 2/20 0.46
▸ CDK1 P06493 2/20 0.46
▸ CSF1R P07333 2/20 0.46
▸ FGFR1 P11362 2/20 0.46
▸ FLT1 P17948 2/20 0.46
▸ MARK3 P27448 2/20 0.46
▸ KDR P35968 2/20 0.46
▸ FLT3 P36888 2/20 0.46
▸ MAPK8 P45983 2/20 0.46
▸ MAPK9 P45984 2/20 0.46
▸ GSK3A P49840 2/20 0.46
▸ NEK2 P51955 2/20 0.46
▸ LIMK1 P53667 2/20 0.46
▸ MAPK12 P53778 2/20 0.46
▸ CSNK2A1 P68400 2/20 0.46
▸ DYRK1A Q13627 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19476829 1.00 EHMT2 (0.55) EHMT2EHMT1IGF1RPLK4AURKA
SCHEMBL19477462 1.00 EHMT2 (0.55) EHMT2EHMT1IGF1RPLK4AURKA
SCHEMBL19477457 0.86 AURKA (0.49) EHMT2EHMT1IGF1RPLK4AURKA
SCHEMBL19477463 0.86 AURKA (0.49) EHMT2EHMT1IGF1RPLK4AURKA
SCHEMBL19477454 0.86 AURKA (0.49) EHMT2EHMT1IGF1RPLK4AURKA
SCHEMBL19476861 0.85 EHMT2 (0.74) EHMT2EHMT1IGF1RKDRCDK2
SCHEMBL30367701 0.83 EHMT2 (0.77) EHMT2EHMT1IGF1RKDRCDK2
SCHEMBL19462482 0.83 EHMT2 (0.77) EHMT2EHMT1IGF1RKDRCDK2
SCHEMBL19476841 0.83 EHMT2 (0.53) EHMT2EHMT1IGF1RPLK4AURKA
SCHEMBL19476815 0.83 EHMT2 (0.53) EHMT2EHMT1IGF1RPLK4AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3442947-B1 AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS AS EHMT1 AND EHMT2 INHIBITORS EPIZYME INC (US) 2023-06-07 — — EP disclosed
US-20210213014-A1 METHODS OF USING EHMT2 INHIBITORS IN IMMUNOTHERAPIES Epizyme, Inc. 2021-07-15 — — US disclosed
US-20210198277-A1 AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS Epizyme, Inc. 2021-07-01 — — US disclosed
US-20170355712-A1 AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS Epizyme, Inc. 2017-12-14 — — US disclosed
US-20170355712-A1 AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS Epizyme, Inc. 2017-12-14 — — US disclosed
WO-2017181177-A1 AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS AS EHMT1 AND EHMT2 INHIBITORS Epizyme, Inc. (US) 2017-10-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355712-A1 AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS SHMT1, BHMT, BHMT2 EHMT2 4/4885EHMT1 7/4885IGF1R 4094/4885
US-20210198277-A1 AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS SHMT1, BHMT, BHMT2 EHMT2 4/4885EHMT1 7/4885IGF1R 4094/4885
US-20210213014-A1 METHODS OF USING EHMT2 INHIBITORS IN IMMUNOTHERAPIES EHMT2, BHMT2, BHMT EHMT2 1/4885EHMT1 4/4885IGF1R 4311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.